ConductScience.org, home

Paper56980

BACON (bleomycin, adriamycin, CCNU, oncovin and nitrogen mustard) in squamous lung cancer. Experience in fifty patients.

Livingston RB and 6 others. Cancer, 1976. Cited by 69 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. BACON (bleomycin, adriamycin, CCNU, oncovin and nitrogen mustard) in squamous lung cancer. Experience in fifty patients. Papers, record 56980. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/56980

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
BACON (bleomycin, adriamycin, CCNU, oncovin and nitrogen mustard) in squamous lung cancer. Experience in fifty patients.
PubMed
Journal
Cancer
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
69
iCite
Relative citation ratio, by iCite
4.7
iCite
Revised in PubMed
2019-06-19
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Livingston RBR B
2Fee WHW H
3Einhorn LHL H
4Burgess MAM A
5Freireich EJE J
6Gottlieb JAJ A
7Farber MOM O

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
Lung NeoplasmsMajor topic
Bleomycin
Clinical Trials as Topic
Doxorubicin
Drug Therapy, Combination
Humans
Lomustine
Male
Mechlorethamine
Vincristine

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.

PMIDTitleJournalYearIn PapersSource
7307235Neurological toxicity of vindesine used in combination chemotherapy of 51 human solid tumors.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7307235PubMed
7307230Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcinoma of the lung. Therapeutic efficacy, toxicity, and pharmacokinetics.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7307230PubMed
7083461VP16-213 and cyclophosphamide in non oat cell bronchogenic carcinoma.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/7083461PubMed
6156836111In-bleomycin imaging of breast tumours.Eur J Nucl Med1980https://conductscience.org/library/papers/6156836PubMed
4060103Chemotherapy in non-small cell bronchial carcinoma.Thorax1985https://conductscience.org/library/papers/4060103PubMed
2414458Update in cancer chemotherapy, Part III: Lung cancer, Part 1.J Natl Med Assoc1985https://conductscience.org/library/papers/2414458PubMed
232314Small cell carcinoma: combined approach to treatment.Thorax1979https://conductscience.org/library/papers/232314PubMed
146331[Combination chemotherapy in patients with disseminated bronchogenic carcinoma (author's transl)].Z Krebsforsch Klin Onkol Cancer Res Clin Oncol1977https://conductscience.org/library/papers/146331PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/56980

GET https://conductscience.org/api/papers/v1/56980/authors